Cipher Capital LP Tg Therapeutics, Inc. Transaction History

Cipher Capital LP

$211 Million
Q1 2024

A detailed history of Cipher Capital LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cipher Capital LP holds 11,525 shares of TGTX stock, worth $340,448. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,525

Holding current value

$340,448

% of portfolio

0.08%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $150,055 - $245,482	11,525 New	11,525 $175,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $47,980 - $88,191	10,499 New	10,499 $62,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$455 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$336 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$269 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$106 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$94.7 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cipher Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Cipher Capital LP with notifications on news.

Account